Gene · 406943
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system. | Commun Biol | 2023 | 37217597 | PubTator, text mining | PubMed |
| In Silico Analysis of MicroRNA Expression Data in Liver Cancer. | Cancer Inform | 2023 | 37200943 | PubTator, text mining | PubMed |
| The miR-148/152 family contributes to angiogenesis of human pluripotent stem cell- derived endothelial cells by inhibiting MEOX2. | Mol Ther Nucleic Acids | 2023 | 37200858 | PubTator, text mining | PubMed |
| The potential regulatory role of RNA methylation in ovarian cancer. | RNA Biol | 2023 | 37194218 | PubTator, text mining | PubMed |
| Connection of Cancer Exosomal LncRNAs, Sponging miRNAs, and Exosomal Processing and Their Potential Modulation by Natural Products. | Cancers (Basel) | 2023 | 37190145 | PubTator, text mining | PubMed |
| Potassium Channels, Glucose Metabolism and Glycosylation in Cancer Cells. | Int J Mol Sci | 2023 | 37175655 | PubTator, text mining | PubMed |
| Cancer Stem Cells and Prostate Cancer: A Narrative Review. | Int J Mol Sci | 2023 | 37175453 | PubTator, text mining | PubMed |
| ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. | Int J Mol Sci | 2023 | 37175410 | PubTator, text mining | PubMed |
| Identification of Exo-miRNAs: A Summary of the Efforts in Translational Studies Involving Triple-Negative Breast Cancer. | Cells | 2023 | 37174739 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Packaged miR-195-5p Sensitizes Melanoma to Targeted Therapy with Kinase Inhibitors. | Cells | 2023 | 37174717 | PubTator, text mining | PubMed |
| LncRNA HOTAIRM1 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting miR-152-3p/ETS1 axis. | Mol Biol Rep | 2023 | 37171551 | PubTator, text mining | PubMed |
| Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer. | Front Genet | 2023 | 37153003 | PubTator, text mining | PubMed |
| The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions. | Front Endocrinol (Lausanne) | 2023 | 37152960 | PubTator, text mining | PubMed |
| The miR-126-5p and miR-212-3p in the extracellular vesicles activate monocytes in the early stage of radiation-induced vascular inflammation implicated in atherosclerosis. | J Extracell Vesicles | 2023 | 37140946 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management. | Int J Mol Sci | 2023 | 37108371 | PubTator, text mining | PubMed |
| A Mixture Method for Robust Detection HCV Early Diagnosis Biomarker with ML Approach and Molecular Docking. | Int J Mol Sci | 2023 | 37108370 | PubTator, text mining | PubMed |
| An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. | Genes (Basel) | 2023 | 37107631 | PubTator, text mining | PubMed |
| Dimerization of Transmembrane Proteins in Cancer Immunotherapy. | Membranes (Basel) | 2023 | 37103820 | PubTator, text mining | PubMed |
| Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response. | Front Pharmacol | 2023 | 37063265 | PubTator, text mining | PubMed |
| Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions. | Mol Cancer Res | 2023 | 37052491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406943/papers?page=9